Business
Currency:USD
2024/FY
Stock NameRevenueRatio
Immunotherapies310.2M100.00%
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States226.69M73.08%
Europe73.22M23.61%
International10.08M3.25%
Genentech213K0.07%